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Abstract. A 7-year-old boy presented with bilateral ptosis and atypical retinitis pigmentosa. 
Before age two, he had had an Fe-refractory anemia, with neutropenia and thrombopenia. Just 
prior to the ophthalmic examination, the patient developed lactate acidosis, muscular hypo- 
tonia, ataxia and increased protein in the spinal fluid. Pancytopenia, pancreas dysfunction and 
growth retardation are the main features of Pearson's yndrome, most children not surviving 
beyond age three. The cause of Pearson's yndrome in our patient turned out to be a 5 kb 
deletion in the mitchondrial DNA. Similar deletions have been described in the Kearns-Sayre 
syndrome. It seems that children who survive the initial phase of Pearson's yndrome, may 
develop Kearns-Sayre syndrome. 
Introduction 
In all likelihood, the mitochondria in our cells were originally bacteria. As 
these bacteria entered our cells, they brought their own DNA, coding for 
aerobic metabolism, with them (see for short review: Palca, 1990). The 
16569-base-pair (bp) long, circular, mitochondrial DNA (mtDNA) within 
our cells contains the code for some 13 proteins, some of which serve as 
(parts of) enzymes in the Krebs-cycle: NADH-dehydrogenase, succinate- 
dehydrogenase, cytochrome-B, cytochrome-C-oxydase nd ATP-synthetase. 
Mitochondria are inherited only maternally, via the ovum. Each cell has 
2-100 mitochondria. One mitochondrion has 4-10mtDNA copies. The 
mutation frequency is only approximately 1% per 10 6 years but, unlike 
nuclear DNA, mutations in the mtDNA cannot be repaired. 
In mtDNA point-mutations, as in Leber's optic neuropathy, one of the 
16569 base pairs is altered. In mtDNA deletions, as in the Kearns-Sayre 
syndrome (progressive external ophthalmoplegia, retinitis pigmentosa, onset 
before age 20, and one or more of the following: complete heart block, 
cerebrospinal fluid protein level above 1g/L, and cerebellar syndrome), a
piece of mtDNA is missing. The DNA with the deletion is shorter and it 
seems plausible that this causes it to multiply faster than the normal mtDNA 
74 
la 
lb 
Fig. 1. The fundus of the right eye of the patient at presentation (panel a) showed an atypical 
retinitis pigmentosa, most outspoken in the periphery, but also present in the macular area. 
Two years later (panel b), the retinitis had progressed slightly, with more pigment clumping 
in the macula. The lower nasal periphery of the fundus of the left eye at presentation 
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(panel c) showed the most pronounced pigment changes at the time. Two years later, the lower 
temporal periphery (panel d) showed similar pigment changes. As in the right eye, the macula 
of the left eye (upper left in panel d), now showed pigment clumping. 
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in the same cell thus causing an increasing proportion of anomalous mtDNA 
over the years, and hence, progression of the disease. We were confronted 
with a case that had all the characteristics of the Kearns-Sayre syndrome but 
had, however, years before been diagnosed as the Pearson syndrome 
(Pearson et al., 1979). 
Case report 
A 7-year-old boy presented with bilateral incomplete ptosis and an atypical 
retinitis pigmentosa, more outspoken in the nasal periphery, but also 
affecting the central retina (Fig. 1, upper panels). Visual acuity was 1.0 in 
both eyes, and color vision (Ishihara plates) was normal. He had slight 
concentric limitation of the motility of both eyes. He had been treated 
previously with corticosteroid eye drops for recurring dots on the cornea 
associated with oedema, similar in appearance, asthe referring ophthalmol- 
ogist noted, to keratitis photoelectrica. Before age two, he had had anemia 
that could not be relieved with iron, with neutropenia nd thrombopenia. 
The pancytopenia remitted spontaneously, but physical and mental develop- 
ment was retarded. At age four, the pancreas was found to be echo-dense 
on ultrasonography and pigment changes were noted on the skin of the 
arms. Just prior to the ophthalmological examination, the patient developed 
lactate acidosis, muscular hypotonia, ataxia and increased protein in the 
spinal fluid. Two years after our first examination the atypical retinitis 
pigmentosa had become more outspoken, with pigment clumping also 
occurring in the macular egion (Fig. 1, lower panels). The ERG was flat: 
The slight concentric limitation of eye motility had hardly progressed. The 
ataxia and other neurologic symptoms were stationary. 
Methods and results 
The cause of Pearson's yndrome in our patient urned out to be a deletion 
in the mitchondrial DNA (described in detail by R6tig et al., 1989). 
Southern blot analysis of leucocyte DNA, digested with restriction enzyme 
PvuII, and hybridization, using a total mitochondrial probe, demonstrated a 
partly deleted ( l lkb)  mtDNA apart from normal mtDNA (Fig. 2). 
Hybridization to the partly deleted mtDNA occurred with cytochrome 
oxidase II and cytochrome b probes, but not with ATPase 6-cytochrome 
oxidase III, NADH dehydrogenase 4 and NADH dehydrogenase 5 probes. 
A 13 bp direct-repeat in the wild-type mtDNA sequence was found to flank 
the 4977 bp deletion, that extended from bp 8483 to 13459 (Fig. 2). 
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Fig. 2. The normal, circular mtDNA consisting of 16569 bp is represented in this diagram by a 
large circle. In the cells of the patient, apart from copies of normal mtDNA, copies of a smaller 
circular mtDNA were also present hat backed the part of the mtDNA designated 'Deletion 
4977 bp'. The parts of mtDNA coding for specific proteins are represented by a doubling of the 
circle and their abbreviated names (A8, A6 etcetera). The five inner bars, designated COX2, 
A6-COX3, etcetera represent the locations of the five probes used to determine the extent of 
the deletion: only cytochrome oxidase II (COX2) and cytochrome b (CYTb) probes hybridized 
with the mtDNA copies with the deletion; the three other probes, ATPase 6-cytochrome 
oxidase III (A6-COX3), NADH dehydrogenase 4 (ND4) and NADH dehydrogenase 5 (ND5), 
found no mirror images to bind to. (This figure was presented previously in a letter-to-the- 
editor describing the genetic defect of the case, R6tig et al., 1989). 
Discussion 
Pancytopenia,  pancreas dysfunction and growth retardat ion are the main 
features of Pearson's syndrome, most children not surviving beyond age 
three. Recently,  lactate acidosis, liver, kidney, intestinal and skin mani-  
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festations have also been described. This case demonstrates that ptosis and 
retinitis pigmentosa, classic features of the Kearns-Sayre syndrome, can 
develop in children who survive the initial phase of Pearson's yndrome. 
The question remains to what extent these two syndromes are actually a 
single syndrome. In a series of studies by Moraes et al. (1989) of 123 
patients with mitochondrial myopathies and encephalopathies, in 44 cases 
mtDNA deletions were found that varied in length between 1.3 and 7.6 kb. 
All of these 44 patients had a Kearns-Sayre syndrome, probable Kearns- 
Sayre syndrome, or progressive xternal ophthalmoplegia. Eleven out of 
fourteen patients with a typical Kearns-Sayre syndrome had mtDNA 
deletions. The deletions were highly variable, and only one small part of the 
mtDNA was deleted in all cases of typical Kearns-Sayre syndrome (ND4, 
coding for part of NADH-dehydrogenase). Two of these eleven patients 
with Kearns-Sayre syndrome and a mtDNA deletion had the same mtDNA 
deletion as our patient. On the other hand, three out of a series of five 
patients with the Pearson syndrome and a mtDNA deletion (R6ting, 1990), 
were found to have the same deletion as our patient. Why does one patient 
with this mtDNA deletion develops the Pearson syndrome and dies of 
Fe-refractory anemia at age two or three, whereas another patient develops 
the Kearns-Sayre syndrome? It has been suggested that heteroplasmy 
(different levels of anomalous mtDNA in different ypes of tissue like eye 
muscles, leucocytes or neuronal tissue) could account for the difference in 
phenotype. Specifically, Holt et al. (1988) found no mtDNA with deletions 
in leucocytes, as opposed to muscle tissue, in patients with the Kearns-Sayre 
syndrome. They attributed this pattern to the frequent cell division of 
leucocyte precursors, allowing selection against the survival of cells with 
deletions in mtDNA. Moraes et al., 1989, however, did find deleted 
mtDNA in leucocytes, but the percentage of mtDNA with deletions was 
much smaller than in muscle tissue. 
Note 
The genetic defect in this case has been described previously in a letter-to-the-editor 
(R6tig et al., 1989). A pediatric report of the case is in print (Baerlocher et al., 
1992). 
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